Harvard leads proteome consortium

Scientists doing target discovery and validation soon will be getting access to a low-cost repository of cloned cDNAs courtesy of Harvard Medical School and an as yet unnamed consortium of academic and corporate partners. The repository will raise the bar for companies that sell genomic databases, clones and expression systems.

Scientists doing target discovery and validation soon will be getting access to a low-cost repository of cloned cDNAs courtesy of Harvard Medical School and an as yet unnamed consortium of academic and corporate partners. The repository will raise the bar for companies that sell genomic databases, clones and expression systems...